Jul 30, 2026 04:08PM
Jul 30, 2026 04:06PM
Jul 30, 2026 04:05PM
Jul 30, 2026 04:05PM
Jun 18, 2026 06:48AM
Jun 2, 2026 10:03AM
Jun 2, 2026 10:02AM Karyopharm's Phase 3 SENTRY Trial of Selinexor Plus Ruxolitinib in Myelofibrosis Selected for Late-Breaking Oral Presentation at EHA 2026
Jun 2, 2026 09:00AM
Jun 2, 2026 08:59AM
May 14, 2026 07:30AM
May 14, 2026 07:30AM
May 14, 2026 07:30AM
May 14, 2026 07:30AM
Apr 21, 2026 10:33AM KPTI phase 3 myelofibrosis trial selected for ASCO presentation
Apr 21, 2026 10:32AM
Mar 30, 2026 09:04AM
Mar 25, 2026 06:55AM
Mar 24, 2026 02:52PM
Mar 24, 2026 09:19AM
Mar 24, 2026 07:18AM
Mar 24, 2026 07:02AM Karyopharm raises $30 million in private placement with RA Capital
Mar 24, 2026 07:01AM
Mar 24, 2026 07:01AM
Mar 24, 2026 07:00AM
Feb 17, 2026 10:48AM
Feb 12, 2026 07:30AM
Jan 12, 2026 07:01AM
Jan 12, 2026 07:00AM Karyopharm Announces Preliminary Unaudited 2025 Revenue and Reiterates Expectation of Delivering Potentially Transformative Phase 3 Data in 2026
Dec 22, 2025 07:06AM
Dec 21, 2025 04:00AM
Nov 3, 2025 07:00AM
Oct 8, 2025 07:01AM
Oct 8, 2025 07:00AM
Sep 10, 2025 07:00AM
Sep 10, 2025 07:00AM Karyopharm Announces Completion of Enrollment in the Phase 3 SENTRY Trial in Myelofibrosis
Aug 11, 2025 07:30AM
May 14, 2025 09:31AM
May 12, 2025 04:05PM
Apr 12, 2025 04:00AM
Feb 24, 2025 08:41AM
Feb 24, 2025 08:40AM
Feb 19, 2025 07:30AM Karyopharm Reports Fourth Quarter and Full Year 2024 Financial Results, Announces Update to Phase 3 XPORT-EC-042 Trial and Highlights Recent Company Progress
Jan 13, 2025 08:30AM
Jan 2, 2025 07:02AM
Jan 2, 2025 07:00AM
Dec 9, 2024 08:00AM
Dec 3, 2024 07:00AM
Nov 18, 2024 07:00AM
Nov 6, 2024 07:57AM Karyopharm Therapeutics (KPTI) PT Raised to $5 at Piper Sandler
Nov 5, 2024 07:30AM

327,204 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All